Steven Paul Ruddock

Title: The Innovations of Steven Paul Ruddock

Introduction

Steven Paul Ruddock is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of biotechnology, particularly in the development of human antibodies. His work focuses on therapeutic applications that address various diseases, including fibrotic and immune/inflammatory conditions.

Latest Patents

Ruddock holds a patent for "Human antibodies specific for TGFβ2." This patent describes specific binding members comprising human antibody antigen binding domains that target human transforming growth factor beta (TGFβ). These members bind specifically to isoforms TGFβ2 and TGFβ1, while preferentially avoiding TGFβ3. The therapeutic utility of these antibodies has been demonstrated through both in vitro and in vivo models, showcasing their potential in treating diseases.

Career Highlights

Throughout his career, Ruddock has worked with prominent organizations such as Cambridge Antibody Technology Limited and the Medical Research Council. His expertise in antibody development has positioned him as a key figure in the biotechnology sector.

Collaborations

Ruddock has collaborated with notable colleagues, including Julia Elizabeth Thompson and Tristan J Vaughan. These partnerships have contributed to the advancement of his research and the successful development of innovative therapeutic solutions.

Conclusion

Steven Paul Ruddock's contributions to the field of biotechnology through his patent and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.